Screening smarter: How Northwell is improving prostate biopsy

While cancer deaths are in decline in the United States, there is one glaring exception: Prostate cancer. Over the last decade, the number of prostate cancer deaths has risen by 3%. Our guest today, Ardeshir Rastinehad, DO, has made it his mission to turn that number around. In addition to his leading role in developing a safer, more accurate approach to prostate biopsies, the former National Institutes of Health researcher is now part of the team at Northwell Health implementing a new fast-track system that has dramatically cut the time it takes to go from screening to diagnosis. Dr. Rastinehad is Northwell Health’s Director for Prostate Cancer and the Vice Chair at the Smith Institute for Urology at Lenox Hill Hospital. Podcast transcript.